Illinois Marijuana Laws

Illinois has made significant progress when it comes to medical marijuana policy, but its laws regarding recreational still lags behind other progressive states. Still, the legislature did recently pass a decriminalization bill that removed criminal penalties for possession of small amounts of marijuana.

Recreational Marijuana in Illinois

Gov. Bruce Rauner signed a decriminalization bill — SB 2228 — on July 29, 2016. The new law, which took effect immediately, makes possession of 10 grams or less of marijuana a civil offense punishable to a fine of up to $200. The law also removes the possibility of a criminal record and those found in possession are no longer subject to arrest or jail time. Municipalities are required to purge citation records for possession every six months.

Possession of 10 to 30 grams of recreational marijuana is considered a misdemeanor if it is a first time personal use offense. Subsequent offense of possessing 10grams to 30 grams will be charged as a felony. First offense of personal use of 30 grams to 500 grams is a charged as a felony, but the offender has to serve a minimum mandatory sentence of 1 year, and maximum jail time is 6 years. The minimum mandatory sentence for subsequent offense is 2 years. The mandatory jail time also applies to sale of more than 10 grams of recreational marijuana as well. Note that first time offenders may be given conditional release.

Medical Marijuana in Illinois

Gov. Pat Quinn signed the Compassionate Use of Medical Cannabis Pilot Program Act to legalize medical marijuana in Illinois, effective August 1, 2013. Public Act 98-0122 allows prescribed users to purchase and use up to 2.5 ounces of marijuana over a 14-day period. To be qualified, patients must acquire a medical marijuana prescription from a doctor who has an established history of treating the patient.

Under the law, patients must obtain medical marijuana only from one of 45 dispensaries authorized by the Illinois Department of Public Health. A caregiver is permitted to pick up medicine for very ill, homebound patients.

In June 2016, Gov. Bruce Rauner approved legislation that extended the state pilot program to at least July 2020 and expanded it to post-traumatic stress disorder (PTSD) and terminal illness.

The following conditions are approved for medical marijuana prescription in the state:

Alzheimer’s Disease
Amyotrophic Lateral Sclerosis (ALS)
Arnold Chiari Malformation
Cachexia or Wasting Syndrome
Chronic Inflammatory Demyelinating Polyneuropathy
Complex Regional Pain Syndrome (Type 2)
Crohn’s Disease
Fibrous Dysplasia
Hepatitis C
Interstitial Cystitis
Multiple Sclerosis (MS)
Muscular Dystrophy
Myasthenia Gravis
Nail-patella Syndrome
Parkinson’s Disease
Post-traumatic Stress Disorder (PTSD)
Preflex Sympathetic Dystrophy
Rheumatoid Arthritis
Sjogren’s Syndrome
Spinal Cord Disease
Spinocerebellar Ataxia (SCA)
Tarlove Cysts
Terminal Illness
Tourette’s Syndrome
Traumatic Brain Injury (TBI) and Post-Concussion Syndrome

Consumption of CBD from Hemp Oil in Illinois

The purchase and consumption of CBD hemp oil is federally legal, as CBD hemp oil falls under the same importation and commerce laws as other hemp products. Illinois has passed no further legislation specifically related to CBD hemp oil.

Cultivation of Cannabis in Illinois

Personal cultivation of marijuana is illegal in Illinois, even for medical marijuana patients and caregivers. Cultivation of less than 5 plants is a misdemeanor punishable by a 1-year maximum jail sentence. Cultivating anything more 5 plants can result in a minimum mandatory sentence of up to 4 years and a maximum fine of up to $100,000.

In 2014, the state passed the Cannabis Control Act, which allows the cultivation of industrial hemp for agricultural or academic research. All sites that are used to grow hemp must be registered with local authorities, as well as the department of agriculture.


DISCLAIMER: The information contained in this website is for general information purposes only; it does not constitute legal advice. Although we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Therefore, any reliance you place on such information is strictly at your own risk.

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.